First Time Loading...

Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3

Watchlist Manager
Dimed SA Distribuidora de Medicamentos Logo
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
Watchlist
Price: 10.94 BRL -0.55% Market Closed
Updated: May 19, 2024
Section:
 

Relative Value

The Relative Value of one PNVL3 stock under the Base Case scenario is 16.2 BRL. Compared to the current market price of 10.94 BRL, Dimed SA Distribuidora de Medicamentos is Undervalued by 32%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PNVL3 Relative Value
Base Case
16.2 BRL
Undervaluation 32%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.4
P/S
P/S
Price to Sales
0.4
vs History
95
vs Industry
58
Median 3Y
0.5
Median 5Y
0.6
Industry
0.6
Forward
0.3
More Details
17.5
P/E
P/E
Price to Earnings
17.5
vs History
90
vs Industry
29
Median 3Y
21.1
Median 5Y
23.1
Industry
16.5
Forward
8.8
More Details
5.5
P/OCF
P/OCF
Price to OCF
5.5
vs History
98
vs Industry
46
Median 3Y
7.7
Median 5Y
14.7
Industry
8
More Details
12.7
P/FCFE
P/FCFE
Price to FCFE
12.7
vs History
46
vs Industry
33
Median 3Y
-9.6
Median 5Y
8.3
Industry
16.1
More Details
1.4
P/B
P/B
Price to Book Value
1.4
vs History
87
vs Industry
47
Median 3Y
1.6
Median 5Y
2
Industry
1.7
More Details
0.5
EV/S
EV/S
Enterprise Value to Sales
0.5
vs History
95
vs Industry
54
Median 3Y
0.6
Median 5Y
0.7
Industry
0.7
Forward
0.4
More Details
1.6
EV/GP
EV/GP
Enterprise Value to Gross Profit
1.6
vs History
93
vs Industry
56
Median 3Y
1.8
Median 5Y
2.4
Industry
2.3
More Details
5.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
5.9
vs History
95
vs Industry
47
Median 3Y
6.9
Median 5Y
9.4
Industry
8.4
Forward
6.1
More Details
13.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
13.2
vs History
95
vs Industry
31
Median 3Y
17
Median 5Y
20.9
Industry
12.8
Forward
8.8
More Details
7.2
EV/OCF
EV/OCF
Enterprise Value to OCF
7.2
vs History
93
vs Industry
43
Median 3Y
10.1
Median 5Y
17.1
Industry
9
More Details
13.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
13.6
vs History
69
vs Industry
29
Median 3Y
14.6
Median 5Y
26.5
Industry
12.6
More Details
1
EV/IC
EV/IC
Enterprise Value to IC
1
vs History
85
vs Industry
44
Median 3Y
1.1
Median 5Y
1.4
Industry
1.1
More Details

Multiples Across Competitors

PNVL3 Competitors Multiples
Dimed SA Distribuidora de Medicamentos Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
BR
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
1.6B BRL 0.4 17.5 5.9 13.2
ZA
Clicks Group Ltd
JSE:CLS
75.5B Zac 0 0 0 0
ZA
Dis-Chem Pharmacies Ltd
JSE:DCP
28.8B Zac 0 0 0 0
US
Walgreens Boots Alliance Inc
NASDAQ:WBA
15.7B USD 0.1 -2.6 5.3 11.9
BR
Raia Drogasil SA
BOVESPA:RADL3
47.3B BRL 1.4 44.9 13.5 24.1
JP
MatsukiyoCocokara & Co
TSE:3088
979B JPY 1 18.7 8.8 11.4
CN
Yifeng Pharmacy Chain Co Ltd
SSE:603939
45.1B CNY 1.9 30.4 23.1 23.1
MX
Corporativo Fragua SAB de CV
BMV:FRAGUAB
82.1B MXN 0.7 17.1 7.8 9.3
SA
Al Nahdi Medical Company SCJSC
SAU:4164
17.6B SAR 2 19.7 11.1 18.3
CN
DaShenLin Pharmaceutical Group Co Ltd
SSE:603233
26.1B CNY 1 24.4 19.2 19.2
JP
Cosmos Pharmaceutical Corp
TSE:3349
559.2B JPY 0.6 22.5 10.9 17.3

See Also

Summary
PNVL3 intrinsic value, competitors valuation, and company profile.
DCF Valuation
PNVL3 stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PNVL3 stock valuation using valuation multiples.
Wall Street Estimates
PNVL3 price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PNVL3 stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.